Dokumeds

This article relies excessively on references to primary sources. Please improve this article by adding secondary or tertiary sources. Find sources: "Dokumeds" – news · newspapers · books · scholar · JSTOR (March 2010) (Learn how and when to remove this message)

DOKUMEDS

Company type	Private
Industry	Contract research organization Pharmaceutical Medical device Life sciences Consulting
Founded	1995; 29 years ago (1995)
Headquarters	Riga, Latvia
Services	Support services for pharmaceutical, biotech and medical companies
Revenue	8,307,219 Euro (2022)
Net income	867,980 Euro (2022)
Total assets	5,032,347 Euro (2022)
Number of employees	63 (2022)
Website	www.dokumeds.com

DOKUMEDS is European Clinical Research Organization (CRO) providing a comprehensive range of services for clinical research focused primarily on Phase I-IV clinical trials and development to the pharmaceutical, biotechnology and medical device industry. Established in 1995, Dokumeds has been expanding its coverage and services significantly over 25 years of operations. Gradual geographical and operational coverage expansion has correlated with company staff growth and lowering of employee turnover. Nowadays Dokumeds is a leading international CRO with operational capabilities in 30+ countries in Europe, Africa, and other regions.

Apart from a full cycle of services for Phase I – IV clinical development programs, Dokumeds functional service provision capabilities are:^{[citation needed]}

• Feasibility Services
• Study Start-up services
• Regulatory consultancy & submissions
• Contract & Payment management
• IP & Supply logistics
• Training
• Medical monitoring & Medical review
• Medical writing
• Pharmacovigilance
• Enrolment Liaison
• Outsourcing of staff
• Site audits

DOKUMEDS has offices in:

• Russia
• Ukraine
• Poland
• Latvia
• Lithuania
• Estonia
• Bulgaria
• Germany
• Romania
• South Africa

DOKUMEDS has been operating in the field of clinical trials for 25 years, founded in 1995.^[1][2]